Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Completed × tanespimycin × Clear all

Phase

Phase 1 16 Phase 2 10 Phase 1/2 2 Phase 3 1 Phase 2/3 1

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Cyclophosphamide 251 Cisplatin 241 Radiotherapy 217 Paclitaxel 207 Docetaxel 192 Fluorouracil 187 Carboplatin 187 Doxorubicin 185 Dexamethasone 145 Gemcitabine 130 Vincristine 122 Capecitabine 110 Prednisone 109 Etoposide 109 Leucovorin 104 Bevacizumab 101 Methotrexate 100 Rituximab 95 Cytarabine 93 Filgrastim 82 Trastuzumab 81 Oxaliplatin 75 pembrolizumab 66 Pemetrexed 60 Drug Therapy 59 Tamoxifen 58 Epirubicin 53 Chemotherapy, Adjuvant 51 Irinotecan 50 Granulocyte Colony-Stimulating Factor 50

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00546780 2011-06-28

BMS TIME-1

Bristol-Myers Squibb

Phase 3 Completed

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡